XBiotech posts Phase 1 results for Natrunix dose-escalation study in healthy volunteersTrial updatenatrunixXBiotech, Inc.
XBiotech posts results for XB2001 pancreatic cancer trial, over five years after registrationTrial updateXB2001XBiotech, Inc.
Sign inSign in